Search This Blog

Thursday, August 11, 2022

Novartis to Update Zolgensma Labeling

 NOVARTIS - FOLLOWING 2 RECENT PATIENT FATALITIES IN ZOLGENSMA GENE THERAPY CO WILL BE UPDATING LABELING TO SPECIFY FATAL ACUTE LIVER FAILURE REPORTED

https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Says-Following-two-Recent-Patient-Fatalities-In-Zolgensma-Gene-Therapy-Co-Will-Update-Labe-41287370/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.